THROMBOSIS RESEARCH 51; 533-541, 1988 0049-3848/88 $3.00 t .OO Printed in the USA. Copyright
(c) 1988 Pergamon
Press plc.
Al1 rights reserved.
RADIOIMMUNOASSAY OF THROMBOXANE B2 IN PLASMA: METHODOLOGICAL MODIFICATIONS
P.G. Rogasi, R. Paniccia, M. Coppo, D. Prisco, M. Boddi, J. Chent G.F. Gensini, R. Abbate Clinica Medica
1, University
of Florence,
Italy
in original form 12.5.1988 by Editor P.M. Mannucci) (Received by Executive Editorial Office 28.6.1988)
(Received 2.5.1988; Accepted
ABSTRACT Thromboxane commercial
82
(TxB2) determination
3H-RIA
kits.
in plasma are not detectable this the
study is the
is usually performed
However, the without
evaluation
by
low amounts of TxB2
previous extraction.
The aim of
of 1) plasma protein interferences
on
binding and separation
charcoal
steps of bound from free analyte and 2) Our results in different experimental conditions.
efficacy
indicate that plasma proteins do not influence the antibody the efficacy of precipitation but significantly reduce dextran-charcoal,
so that the
protein amount increase
buffer. Our findings plasma
TxB2
supernate radioactivity
(r= 0.99 pcO.001).
in the samples counts concentration in plasma of
using present
suggest
without
that, in
extraction,
rises with the
Such greater
determines a lower when the calibration
binding, of kit
number
of
estimation of TxB2 curve is set up in
order to measure
low amounts
it is useful: 1) to refer to a
Chinese *from the Cardiovascular Institute and Fu Wai Hospita1 Academy of Medical Sciences. Peking - China; recipient of a Research Award from Italian Government. ____________________~~_~_~__~~~~~~_~~~____~_~____~~~~~__~~~~~~__~~~~~~~~~~~~~ Key words: Radioimmunoassay,
Thromboxane
82.
533
Vol. 51, No. 5
RADIOIMMUNOASSAY OF PLASMA TxB2
534
calibration
2) to use curve set up in buffer-diluted plasma, charcoal concentration allowing the lowest stripping
uncoated 3) to perform al1 steps at 4OC.
the and
INTRODUCTION is the most widely employed method for the Radioimmunoassay (RIA) quantitative determination of thromboxane 82 (TxB2) levels in biological mainly in plasma or serum and in urine (1,2). The large amounts of fluids, TxBP present in serum are easily measurable after adequate dilutions, whereas the
lower
amounts in urine
need extraction
and
concentration.
As
plasma
RIA raises some difficulties because of the low TxBE samples are concerned, - near to the detection limit of the commonly used RIA - present in levels plasma (3). In order to concentrate
TxB2 and to remove al1 plasma
interfere
with
the assay,
in many laboratories
performed.
However, these procedures
introduce
substances which could
extraction
some drawbacks
procedures
are
(4): 1) recove-
ry, which has to be estimated
on each plasma sample, may be low and variable;
2) impurities
solvents and
deriving from
gases
column leakages and so forth, may contaminate tions
and chromatographies
remove plasma
used for evaporation,
from
the sample, even though extrac-
materials
possibly interfering
in
the assay; 3) capacity, rapidity and handiness of the method are diminished by pretreatment of samples. These concerns could be avoided by performing the
assay
on
plasma
chromatographic widely
used
samples,
purification.
RIA kits (NEN,
present in unextracted
previous some
solvent
extraction
commercially
or
available
ABT) fail to detect the low amounts of TxB2 (5). This failure could be due to interferences
plasma
exerted by plasma components
without
Unfortunately,
in some step of the assay.
The aim of our study was to set up a suitable and reliable procedure for
the
assay
the
of
variables procedures)
TxB2 in unextracted (incubation
plasma.
For this purpose we have studied
temperature
and bound from free analyte separation on the various phases of the TxB2 RIA in the (6-11).
possibly interfering
presence of plasma proteins
MATERIALS
AND METHODS
Materials:
American Biomedical Technologies (ABT) 3H-RIA kit for TxB2 was purchased from AFB Clinical Pharmacology Inc (Berlin). Liquid scintillation fluid: Aquassure, New England Nuclear (NEN, Boston, MA, USA). Charcoal: activated powder "Norit A", Serva (Feinbiochemica, Heidelberg, West Germany). PGD2, PGE2, bicycle-PGE2, PGF2 alpha, 6-keto-PGFl alpha, (UpJohn, Kalamazoo, Mi, USA). Blood sampling and preparation _ were drawn,
after a three-day
prostaglandin-free
oral acetyl-salicylic
plasma.
Nine mL of blood
acid treatment
(lg/die),
Vol. 51, No. 5
RADIOIMMUNOASSAY OF PLASMA TxBP
from 15 healthy volunteers, of
10 ug/mL phenoprophen
platelet-poor 4oc,
were
plasma,
into cold polypropylene
535
syringes containing
in 0.037 mmol/L EDTA solution.
obtained
by centrifuging
1 mL
Fourteen volumes of
at 3200 x g for 30 minutes at - 10% suspension
treated with one volume of the proper charcoal
(w/v) in phosphate buffer (20 mmol/L, pH 7.4, diluted 1:12 with twicedistilled water) vortexed and centrifuged at 4OC for 10 minutes at 3200 x g. Lastly it was two-fold Experimental 1)
leached and stored at -2OOC.
procedure two influence ---of plasma on the standard curve, 10, 25, 50, 100, 250, 500 and 1000
In order to evaluate the
series
of
standard
TxB2
pg/mL were prepared. in TxB2
and in buffer,
plasma: 100 vl_ of each standard dilution, both in were transferred into the assay tubes; 100 uL of 3H-
and 100 uL of anti-TxB2
taining 100
The first series was set up in assay buffer, the second
prostaglandin-free
plasma
dilutions:
antibody were then added.O-standard
100 uL of buffer or prostaglandin-free
uL of antibody)
Al1 the tubes were thoroughly (25OC)
100
and "NSB" tubes (containing either
100 uL of plasma + 100 uL of buffer and temperature
plasma,
tubes (con-
uL of tracer and
200 uL of buffer
or
100 I.ILof tracer 1 were also prepared.
mixed and allowed to incubate overnight
together with total count tubes (containing
at room
700
uL
of
buffer or 100 FL of plasma t 600 uL of buffer and 100 uL of tracer). The
day after 500 UL of dextran-coated
bath under continous
charcoal
tube. After a contact time of 10 minutes 1000 x g for 10 were
minutes
transferred
scintillation triplicate.
into
cocktail After
beta counter minutes/vial.
suspension
(placed in an ice
stirring at least 1 hr before) were added to each in a liquid were
(+ 5') the
refrigerated
centrifuge vials scintillation
added.
Al1 the
a 3-hour dark adaptation
(Beckman Instruments
Inc.,
assay
tubes were centrifuged (4OC). and 5
procedure
was
performed
al1 the vials were counted
Fullerton,
The binding capacity of the antibody was calculated
at
The supernates ml of liquid
Calif.,
USA)
in
for
in a 10
according to the formula:
0 standard - NSB x100 Total counts 2)
For assessing the various charcoals -in the separation phase we compared supplied by ABT kit with albumin-coated charcoalcharcoal pH 7.3) uncoated charcoal 0.5% (w/v) in phosphate buffer (10 mmol/L,
dextran-coated containing different
bovine albumin concentrations
(0.4% w/v) - and uncoated charcoal in phosphate
prepared at four
buffer (described above):
1, 5, 10 and
50 g/L. Each charcoal preparation, stored at 4OC for 24 hrs and placed in an ice bath under continuous stirring at least 1 hr before, was added to six NSB tubes (containing 100 uL of prostaglandin-free plasma, 100 JJL of buffer and 100 uL of 3H-TxB2) and to six 0-standard tubes (containing 100 ~.JL of prostaglandin-free plasma, 100 uL of 3H-TxB2 and 100 flL of antibody). After a 10 - minute
contact, centrifugation
according to the procedure described
and counting above.
procedures
were
performed
536
Vol. 51, No. 5
RADIOIMMUNOASSAY OF PLASMA TxB2
3) The uncoated
influence
efficiency
was
by on the separation charcoal the Üñcoated this by ABT. To supplied
of plasma protein concentration
charcoal
(5
g/L)
was investigated
and
compared with dextran-charcoal containing 100 ul of up a series of NSB samples plasma/buffer at increasing ratios (O%, 30%, 50%, 70%,
set purpose we prostaglandin-free
lOO%), 100 uL of buffer and fixed amounts (100 uL) of labeled analyte and a of 0-standard samples containing the same increasing concentrations series 100 uL of tracer and 100 ML of antibody, in of prostaglandin-free plasma, The two sample series were incubated overnight at 25OC. The day sextuple. after the samples (triplicate NSB and 0-standard) were treated either with uncoated
charcoal
or
with dextran-coated
charcoal,
following
the
usual
For calculating the binding a group of total count tubes procedure. containing the same plasma protein final concentrations was set up, incubated and counted. Al1 the procedure was performed in sextuple. 4)
Finally
we
manufacturers
investigated of
the -effect of temperature on the assay. the ABT assay kit allow the antigen-antibody reaction
the addition of cold charcoal
in both the phases of the
assay, we
prepared four groups of samples: A, B, C and Cl . Each group consisted of NSB tubes (50 VL of prostaglandin-free tracer) and six 0-standard of
buffer,
separation uncoated of
100 of
tubes (50 uL of
uL of tracer, bound
charcoal
prostaglandin-free
100 uL of antibody).
from free analyte was obtained
(5 g/L).
prostaglandin-free
plasma + 150 VL of buffer,
Moreover we set
100 uL
six of
plasma t 50 PL
In al1 the groups by
and
In order
keeping the tubes at room temperature.
to evaluate the influence of temperature
The
addition
of
the cold
up six total count tubes (50 uL
plasma t 650 uL of buffer and 100 GIL of tracer), whose
average radioactivity was used for calculating the antibody capacity. Group A tubes were allowed to incubate at 4OC and the separation phase (addition of uncoated charcoal and centrifugation) was performed keeping the tubes at 4OC. In group B both incubation and separation, were performed keeping the tubes at 25OC. Group C tubes were incubated at 25OC, whereas separation step was carried out at 4OC. separation at 25OC. In
addition,
temperature overnight
In group D incubation was performed at 4OC
in order to furtherly confirm the influence of the
and
incubation
on NSB, we set up four series of six NSB tubes and incubated them
respectively
at 4OC,
treated with uncoated charcoal only variable. Statistical
analysis.
statistical
analysis
15OC,
25OC and 37OC.
Al1 these samples were
at 4OC, so that incubation temperature was the
Results are given as mean t standard deviation. The was performed by following tests: Wilcoxon rank- sum test for unpaired data and linear regression analysis (12-13).
RESULTS AND DISCUSSION 1)
Influence
of plasma on the standard curve. A standard curve
set
up
in
Vol. 51, No. 5
RADIOIMMUNOASSAY
prostaglandin-free
plasma and the
suggested
by the manufacturers
Standard
curve
in
plasma
OF PLASMA TxB2
537
usual standard curve set up in buffer
as
are shown in Figure 1.
does not superimpose
the
curve
in
buffer
but
parallels
it, i.e. for each dilution of TxB2 standard higher radioactivity is observed in plasma than in buffer. This can account for the underestimation, or undetectability, of TxB2 in unextracted plasma samples when the standard reference curve is set up in buffer. The binding capacity of the antibody in the
two
values
conditions are
The differente that
a
by
an
different.
3-fold higher
in radioactivity
variation
explained
is not significantly
approximately
(~0.001)
On
the
contrary
in plasma than in
levels of the two reference curves,
in the binding of the
antibody
is ruled
impaired activity of the dextran-coated
out
can be in the
,
charcoal
presence of plasma proteins. In fact the very high levels of that the separation of bound from free TxB2 is not complete.
NSB
NSB
buffer. provided
indicate
2000
1500
P) 3 .z 1000 ài P Y c 0” 0
500 o plasma 0 buffer
+/
g 10
1
25
I
50
I
100
Thromboxane
Comparison
FIG.1 plasma;
(0)
of two standard curves:
I
I
250
500
10’00 (rm/mU
62
(0)
set
up in prostag 1andin-free
set up in buffer.
2) Assessment --of various charcoal preparations -in the separation . phase. The binding capacity of the antibody and efficiency of the separation of bound from free analyte in undiluted plasma performed with dextran-coated charcoal, charcoal-albumin in
Figure 2.
and uncoated charcoal Uncoated charcoal
at
various concentrations
at 5 g/L is more efficient
are
than dextran
shown and
Vol. 51, No. 5
RADIOIMMUNOASSAY OF PLASMA TxB2
538
albumin-coated
in precipitating
charcoal
free
TxB2 as demonstrated
by
the
lower NSB values. The efficiency is more evident the more concentrated is the charcoal concentration dependent, On the other hand a stepwise, (Figure 2). decrease in the binding capacity of the antibody is observed charcoal.
cpm
(x1001
%
10.
L
9.
I
30.
8.
x
x
7. 6.
e 20. ._ u E ._ m
m 5. v) 24. 3.
10.
2. 1.
1
aten
unco char
COi
1 WL 1 510 uncoated charcoa I
charcoal
charcoal Fig. 2 Use of various -Coating: dextran (Ij, albumin (IJ).
separation
higher
antibody.
The decrease of binding capacity is probably due to the disruption
of antigen-antibody
complexes
experimental
uncoated
charcoal,
step.
the
separation of free TxB2,
of
the
improving
these
(10-50 g/L)
in
Actually,
In
concentrations
preparations
impair the binding capacity of
by charcoal at high concentrations
conditions
uncoated charcoal at 5
g/L
even the
(7,8). concentration
seems to be the most adequate separation procedure, because it implies a minima1 stripping of bound analyte. However, NSB values, even lower, are stil1 exceeding
10% of total counts.
3) --Effect of plasma concentration ----in the assay system on binding capacity and separation efficacy. When samples are treated with uncoated charcoal the NSB values slightly increased (from 210 cpm at 390 cpm) in relation to the increase in plasma/buffer ratio (from 0% to 100%) (r=0.99, pdO.001). Differently when samples are treated with dextran-coated charcoal NSB values markedly increase (from 360 cpm at 921 cpm) with the increase in plasma/buffer ratio (from 0% to 100%) in the assay system (r=0.99 pcO.001). In comparison with the samples treated with uncoated charcoal the radioactivity for each plasma concentration is higher and the slope of the line is steeper. The divergente of the two lines indicates that the better efficiency of uncoated charcoal
Vol. 51, No. 5
RADIOIMMUNOASSAY OF PLASMA TxB2
becomes more evident The
binding
increasing
the concentrations
of plasma (p
capacity of the antibody does not show
using either charcoal the contrary,
preparation
539
significant
at any plasma concentration
when uncoated charcoal
buffer, the binding is significantly
variations
(about 33%). On
is added into the tubes containing
only
lower (p-=O.OOS).
4)
Effect of incubation and separation temperature. Results are shown in -Table 1. The procedure enKely performed at 4OC gives lower NSB and higher
binding
values
than those obtained
manufacturer's
instructions
with
and
group
separation
D
performing
the assay
(group A VS group B).
of group B with group C gives
temperature.
according
to
the
The comparison
of group A
clue
effect
on
the
of
The addition of cold charcoal to the tubes kept in an Table 1
Effect of incubation
and separation
temperature
on NSB, binding and
NSB/TOTAL COUNT ratio Group Incubation temperature
(OC)
A
-B
-C
-D
4
25
25
4
Separation temperature (OC) 4 25 4 25 ____-__-________-__-~~-~~-~~-~~--~--~~-~~-~~-~~~~~~~~~~~~~~~~~~~~ NSB
(cpm)
X 250 316 336 245 SD 10.04 ll.67 19.38 9.31 _________________________-_____-__-__-___________________________
% Binding
x
34.45
31.56
34.48
30.78
SD 1.96 1.18 1.08 1.30 __-__-________-_____-~~-~~-~~-~~-~~-~~-~~-~~-~~~~~~~~~~~~~~~~~~~~ NSB/TOTAL COUNTS % 5.9 7.4 7.9 ________________c___~_~~_~____c_____~~_~_____________________ NSB A VS B
p
eo.001
A VS C
p
CO.001
A VS D
5.8
BINDING p
CO.001
p
-=O.OOl
ns
ns
B VS D
p
-=O.OOl
B VS C
p
CO.05
ns p
p CO.001 C VS D p
bath
and the following
centrifugation
at 4OC give higher binding values
without affecting NSB values. On the contrary the comparisons of group A with group C and of group B with group D give information on the effects of incubation temperature. The in the absente of any effect on incubation at 4OC gives lower NSB values, the binding capacity of the antibody. a positive linear correlation Moreover,
was found between NSB
values
and
FWIOIMMUNOASSAY OF PLASMA TxBP
540
Vol. 51, No. 5
p-=O.OOl).At incubation temperature of 4X, incubation temperature (r= 0.88, 15oc, 25OC and 37OC NSB values were about 210, 390, 410 and 860 cpm respectively. These data could appear quite surprising as one would expect an influence of the incubation temperature on the formation of antigen-antibody and of the separation temperature on the i.e. on the binding, precipitation of free TxB2, indicated by changes in NSB values. The effect of
complexes
the lowering of separation accounted complexes and some with
temperature
for by a decrease by the charcoal.
on the binding of the antibody can
in the disruptive
capacity exerted on the
be
ag-ab
As the relationship between incubation temperature it is conceivable that at a higher temperature
NSB values is concerned,
form of aspecific binding between TxB2 and plasma proteins does occur, This hypothesis less precipitable by charcoal.
formation of complexes
could account for higher values of NSB when separation
is performed
at 25OC.
CONCLUSIONS The
results of our experiments
indicated
by the manufacturers
suggest some modifications
to
the
procedure
of the ABT assay kit so allowing direct assay
of TxB2 in unextracted plasma samples. These modifications are: appropriate dilution of plasma with assay buffer, equal in unknown
1) the samples
and in the
(5 g/L)
standard reference curve; 2) the use of uncoated charcoal
for separation method;
3) the 4OC
By using these modifications and
accuracy
temperature
of the experimental
(Table 2) remain satisfactory,
RIA in unextracted
for incubation procedure,
and separation. the
specificity
whereas the sensitivity
of
the
plasma samples improves.
Table 2 -Characteristics of the modified TxB2 RIA _______-_____-_______^__________________~~_~~~~~~~~~~~~__~_~~____~~~_~______ SENSITIVITY Detection limit: 10
PRECISION pg/mL
CV -intra-assay:
6.60%
-inter-assay:
10.10%
SPECIFICITY: Cross-reactivities
PGDP
1.70%
PGE2, PGF2 alpha
0.07%
6-keto-PGFl
alpha
0.05%
Bicyclo-PGE2
0.05%
ACCURACY
pg added: 10 25 50 100 250 500 1000 (ti= 7) pg assayed: 16 22 39 85 227 427 1071 _______---_____-__________________________~~~~~__~~~~~~_~~______~__~_________
ACKNOWLEDGMENTS This
work was supported
in part by grants from the Consiglio
Ricerche ( N. 87.00382.56 1, Project Atherosclerosis, Ministero Pubblica Istruzione ( 12.01.5625 1
Nazionale delle
Rome, Italy and from
Vol. 51, No. 5
RADIOIMMUNOASSAY OF PLASMA TxB2
541
REFERENCES 1.
GRANSTROM,
E., SAMUELSSON,
and thromboxanes: Prostaglandin
B. Quantitative
genera1 considerations.
and Thromboxane
measurement
of prostaglandins
Frolich JC, ed. Advances in New York: Raven Press, 1978; 5:
In:
Research,
1-13.
2.
SKELLEY D.S., 146-186,
3.
4.
BROWN L.P.,
GRANSTROM
E.
Assay
Samuelsson
B,
Ramwell PW,
Research,
GRANSTROM
E.,
9.
H.
Radioimmunoassay
G.
IJ., EHRLICH K.,
ZETTNER
MULLER-BERGHAUS
of Thromboxane
VIJGH W.J.F.
A.,
"Bound"
8.
KINDHAL
DELVOS
DER
thromboxanes.
In: and
of
Prostaglandins
Direct
B2 in plasma. --Thromb.Res.
Modification
DULY
and
Research,
New
Radioimmunological 39: 767-770, 1985.
of a Commercially
Available
Kit for Higher Precision. --Clin.Chem.21:
3',5'-3H
19:
in Prostaglandin
In: Frolich JC, ed. Methods in Prostaglandin
Radioimmunoassay
7.
Clin,Chem. ---
New York: Raven Press, 1980;6: - 69-76.
-
VAN
and
Paoletti R, ed. Advances
York: Raven Press, 1978; 5: 119-210.
Measurement
6.
Radioimmunoassay.
methods for prostaglandins
Thromboxane
Thromboxanes.
5.
BESCH P.K.
1973.
Digoxin
1172-1174,1975.
P.E. Relative efficacy of separation of "Free" and Pteroylglutamate by charcoal coated with various
materials.
Clin. Chem. 21: 1927-1931, ---
1975.
KUNO-SAKAI incubation
H., SAKAI H. Effects on radioimmunoassay of digoxin of varying periods for antigen-antibody reaction and varying periods for
adsorption
by dextran-coated
charcoal.Clin.Chem.21: ---
227-229,
1975.
charcoal to separate BINOUX M.A., ODELL W.D. Use of dextran-coated antibody bound from free hormone: a critique. -J.Clin.Endocrinol. -Metab.36: 303-310, 1973.
10. LENZ P.
H.,
temperature ll. KEANE P.
WIEN G.H., TOTH J.M.
Standardization
for eight radioimmunoassays.
M.,
WALKER W.
H.
C.,
GAULDIE J.,
aspects of some radioassay. --Clin.Chem.
of incubation time and
Clin.Chem. ---
21: 1169-1171,
ABRAHAM G.
1975.
Thermodynamic
22: 70-73, 1976.
12. WESTGARD Y. O., HUNT M. R. Use and interpretation of common statistical tests in method-comparison studies. --Clin.Chem. 19: 49-57, 1973. 13. WU
G.T.,
comparison
TWOMEY S.L.,
THIERS R.E.
data. --Clin.Chem.
Statistical
21: 315-320,
1975.
evaluation
of
methods-